Insulin glargine
Cold Chain RequiredFDA Approved
Description
Insulin glargine is a long-acting basal insulin analog used for glycemic control in diabetes mellitus. It provides consistent 24-hour glucose control with once-daily dosing. In rare syndromes involving diabetes mellitus as a component, it serves as essential metabolic management.
Indications & Therapeutic Use
Type 1 diabetes mellitus, Type 2 diabetes mellitus, diabetes mellitus in complex syndromes
Linked Diseases:
Global Availability (11 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Insulin glargine
| Generic Name | Insulin glargine |
| Brands | 1 brand available |
| Active Ingredient | Insulin glargine |
| Drug Class | Type 1 diabetes mellitus |
| Manufacturer | Sanofi |
| Dosage Forms | Subcutaneous injection, 100 units/mL, 300 units/mL |
| Medical Code | A10AE04 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00174824 |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes